CXCL8 and cancer: Furthermore, based on our work, it would be interesting in the future to perform extensive preclinical investigations by applying small molecule antagonists such as reparixin and humanized monoclonal antibodies attenuating IL-8 signaling for treatment of human cancer patients detected with hyper-editing.